American Canyon, CA, United States of America

Imtiaz A Chaudry

This inventor holds 27 USPTO granted patents and 5 published patent applications, plus 9 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Dey, L.p., Mylan Specialty LP, Dey Pharma, L.p.. Active years: 2003-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Imtiaz A Chaudry. Retrieved from https://idiyas.com/inventor/imtiaz-a-chaudry-91t4wwia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 70.4



Average Co-Inventor Count = 1.6

ph-index = 8

Forward Citations = 199(Granted Patents)


Location History:

  • Napa, CA (US) (2003 - 2017)
  • American Canyon, CA (US) (2008 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nasal Formulations
Bronchodilators
Pulmonary Hypertension
Rhinosinusitis
Beta-Agonists
Chronic Obstructive Pulmonary Disease
Inhalation Solutions
Formoterol
Albuterol
Fluticasone
Beclomethasone
Pediatric Asthma
27 patents (USPTO):Explore Patents

Title: Innovations in Nasal Drug Delivery: The Contributions of Imtiaz A Chaudry

Introduction

Imtiaz A Chaudry, based in American Canyon, CA, is a prolific inventor known for his significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 27 patents, Chaudry has focused primarily on innovations that enhance drug delivery systems, particularly through nasal administration.

Latest Patents

Among his latest patents, Chaudry has developed nasal pharmaceutical formulations that incorporate a drug substance with a specific particle size distribution profile. This innovative formulation enhances bioavailability, efficacy, and therapeutic effects when administered intranasally. The patented formulations may include corticosteroids, such as fluticasone or its derivatives, to effectively treat symptoms of rhinitis. Additionally, he has worked on bronchodilating beta-agonist compositions suitable for nebulized aerosol administration, which provide effective treatment methods for bronchoconstrictive disorders.

Career Highlights

Chaudry has held significant positions at reputable companies in the pharmaceutical industry, including Dey L.P. and Mylan Specialty LP. His work has played a crucial role in the advancement of drug delivery technologies, particularly in enhancing the therapeutic impact of nasal medications.

Collaborations

Throughout his career, Chaudry has collaborated with notable colleagues such as Partha S Banerjee and Stephen Pham. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of his patents.

Conclusion

Imtiaz A Chaudry's contributions to the field of pharmaceutical innovations have paved the way for advancements in nasal drug delivery systems. His extensive patent portfolio underscores his commitment to improving patient outcomes through effective and efficient drug formulations. As the pharmaceutical landscape continues to evolve, Chaudry's work remains vital to the future of innovative treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…